Skip to content
Clinical Trials – home

Budapest Retina Associates

Research site

Hungary Vaci Ut 76, Kerulet, 1133 Budapest, Hungary

  • 7 trials recruiting
  • Neovascular age-related macular degeneration · Diabetic retinal oedema · Endocrine ophthalmopathy
  • Adults and children

About Specializations

Budapest Retina Associates in Budapest, Hungary specialises in clinical trials of conditions such as Neovascular age-related macular degeneration, Diabetic retinal oedema, Endocrine ophthalmopathy, Dry age-related macular degeneration, and other specialisations. This site conducts important research.

Main research areas of the site

Eye Diseases and Ocular Physiology

At Budapest Retina Associates, clinical research focuses on eye diseases and the function of the retina, with studies centered on conditions that affect central vision and macular health. The trials are designed to assess whether new or improved treatments can better preserve sight and support eye health in people with retinal swelling.

  • Diabetic Macular Edema is being studied to improve treatment options for vision loss related to diabetes.
  • Ocular physiological phenomena are examined to better understand how the eye responds to therapy and disease.
  • Research also includes macular edema secondary to retinal vein occlusion, with a focus on treatment effectiveness and safety.

Overall, the site is contributing to clinical research that evaluates how well different eye treatments work and whether they can offer meaningful benefits for patients with retinal swelling and reduced vision.

Retinal Swelling and Vision Treatment Studies

Clinical trials at this hospital/clinic in Budapest are aimed at improving care for people with diabetic macular edema and macular edema secondary to retinal vein occlusion. The research compares treatment approaches to see which options may provide better vision outcomes while maintaining safety.

  • Studies in diabetic macular edema are evaluating new eye-drop and treatment strategies for effectiveness.
  • Research in retinal vein occlusion focuses on whether a stronger treatment approach can improve visual acuity.
  • The trials aim to support better management of macular edema through more effective and practical therapies.

This research landscape reflects a strong interest in refining therapies for retinal disease, with attention to both visual improvement and patient safety.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Vaci Ut 76, Kerulet1133 BudapestHungary
Recruiting now
7 trials
Conditions studied
12

More sites in BudapestHungary

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

33 clinical trials

Efficacy and safety of ABP 938 compared with aflibercept in participants with neovascular age‑related macular degeneration

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Amgen Inc.

FWY003 in Geographic Atrophy Secondary to Age-Related Macular Degeneration in Patients

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Sponsor:Novartis Pharma AG

A study to compare the efficacy and safety of AVT29 and aflibercept in patients with diabetic macular edema

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Alvotech Swiss AG

Study of Surabgene Lomparvovec Compared to Ranibizumab for Adults with Wet Age-Related Macular Degeneration

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Ranibizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Study of ONL1204 eye injections to slow vision loss in patients with age-related macular degeneration and geographic atrophy

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Xelafaslatide
  • Sponsor:ONL Therapeutics Inc.

Study of oral BI 1815368 compared to placebo in patients with diabetic macular edema over 48 weeks of treatment

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:BI 1815368
  • Sponsor:Boehringer Ingelheim International GmbH

Study of Pozelimab and Cemdisiran for Adults with Geographic Atrophy from Age-Related Macular Degeneration

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Cemdisiran
  • Sponsor:Regeneron Pharmaceuticals Inc.

Optic ischaemic neuropathy

Not yet recruiting

Efficacy and Safety of Intranasal Cenegermin in Adults with Non‑Arteritic Anterior Ischemic Optic Neuropathy (NAION)

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Cenegermin
  • Sponsor:Dompe' Farmaceutici S.p.A.

Long-term Safety and Effectiveness Evaluation of RGX-314 in Patients with Neovascular Age-related Macular Degeneration

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Surabgene lomparvovec
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Endocrine ophthalmopathy

Not yet recruiting

Study on the Effects of VRDN-003 for Patients with Active Thyroid Eye Disease

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:VRDN-003
  • Sponsor:Viridian Therapeutics Inc.

Eyelid ptosis

Not recruiting

Study on the Effectiveness and Safety of Oxymetazoline Hydrochloride Eye Drops for Adults with Acquired Blepharoptosis

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Oxymetazoline Hydrochloride
  • Sponsor:Santen

A study comparing the effectiveness of vorolanib and aflibercept in patients with diabetic macular edema

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Eyepoint Inc.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.